Wednesday, January 5

COVID-19 booster for 12-15 year olds approved by FDA

The EUA for the Pfizer-BioNTech COVID-19 vaccine has been updated to include children between the ages of 12 and 15 years old by the Food and Drug Administration (FDA).

A Pfizer-BioNTech booster dose will be given at least five months after the first immunization, according to FDA authorities.

Some immunocompromised children aged 5 to 11 will be able to get booster doses under the amended EUA.

Acting FDA Commissioner Dr. Janet Woodcock said in a statement that the agency has had to fast adapt to the evolving virus that causes COVID-19 because of the need to make informed decisions with the health and safety of the American public in mind throughout the pandemic.

Woodcock underlined the necessity of maintaining long-standing disease preventive practices.

This latest wave of the Omicron variety calls on us to maintain lifesaving preventative measures including primary vaccine and boosters, mask-wearing, social distancing, etc. in order to effectively battle COVID-19, she stated.

Covid vaccine for children

Pexel photo
No content on this site, regardless of date, should be used to replace direct medical advice from your doctor or another trained practitioner.
Blogger Template Created by pipdig